Diasorin reported EUR91.47M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Brookdale Senior Living USD 4.29B 88.12M Sep/2026
Cencora USD 2.13B 154.91M Jun/2026
Diasorin EUR 91.47M 35.47M Jun/2026
Encompass Health USD 59.9M 837.7M Sep/2026
Enovis USD 259.38M 4.35M Sep/2026
GE HealthCare Technologies USD 1.1B 17M Sep/2026
OPKO Health USD 52.92M 4.32M Jun/2026
Pediatrix Medical Group USD 65.68M 4.89M Dec/2025
Veradigm USD 27.28M 5.24M Dec/2022
Zimmer Biomet Holdings USD 855M 56.6M Sep/2026